IP Library Patent Application 12007143
Patent Application
App. No. 12/007,143

Certain chemical entities, compositions, and methods

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/007,143
Abstract

Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of one or more mitotic kinesins are disclosed.

Claims (11)

1 - 46 . (canceled)

47 . A method for the treatment of a solid tumor comprising administering to a subject in need thereof an effective amount of at least one compound chosen from N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide and pharmaceutically acceptable salts thereof.

48 . A method for the treatment of a solid tumor comprising administering to a subject in need thereof an effective amount of at least one compound chosen from N-{1-[4-(8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl)-benzyl]-3-hydroxy-propyl}-3-chloro-4-isopropoxy-benzamide and pharmaceutically acceptable salts thereof.

49 . A method for the treatment of a solid tumor comprising administering to a subject in need thereof an effective amount of at least one compound chosen from N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-methyl-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide and pharmaceutically acceptable salts thereof.

50 . A method for the treatment of a solid tumor comprising administering to a subject in need thereof an effective amount of at least one compound chosen from N-(2-(2-amino-2-methyl-propionylamino)-1-{4-[8-methyl-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide and pharmaceutically acceptable salts thereof.

51 . A method for the treatment of a solid tumor comprising administering to a subject in need thereof an effective amount of at least one compound chosen from 3-chloro-N-((2S)-1-(2-(dimethylamino)acetamido)-3-(4-(8-(1-hydroxyethyl)imidazo[1,2-a]pyridin-2-yl)phenyl)propan-2-yl)-4-isopropoxybenzamide

and pharmaceutically acceptable salts thereof.

52 . A method for the treatment of a solid tumor comprising administering to a subject in need thereof an effective amount of at least one compound chosen from (S)-3-chloro-N-(1-(2-(dimethylamino)acetamido)-3-(4-(8-methylimidazo[1,2-a]pyridin-2-yl)phenyl)propan-2-yl)-4-isopropoxybenzamide

and pharmaceutically acceptable salts thereof.

53 . A method for the treatment of a solid tumor comprising administering to a subject in need thereof an effective amount of at least one compound chosen from (S)—N-(1-(2-amino-2-methylpropanamido)-3-(4-(8-methylimidazo[1,2-a]pyridin-2-yl)phenyl)propan-2-yl)-3-chloro-4-isopropoxybenzamide

and pharmaceutically acceptable salts thereof.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 16, 2010
From: GLAXOSMITHKLINE LLC
To: CYTOKINETICS, INCORPORATED
Reel/Frame 024245/0367 →
CHANGE OF NAME Recorded Mar 29, 2010
From: SMITHKLINE BEECHAM CORPORATION
To: GLAXOSMITHKLINE LLC
Reel/Frame 024140/0964 →